Alembic Pharma gets tentative nod from USFDA for glycemic control drug
Posted by
www.biotecnika.org
Quoting IQVIA sales data, the company said, Dapagliflozin Tablets,
have an estimated market size of USD 1.7 billion for 12 months, ending
December 2018.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-tentative-nod-from-usfda-for-glycemic-control-drug/articleshow/70342356.cms
Subscribe to:
Post Comments (Atom)
Post a Comment